Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.33 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.33 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.33 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.32 |
| ▸ | GP6 | Q9HCN6 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20619108 | 0.99 | PDK2 (0.32) | ADORA3ALOX15TSHRADORA2AADORA2B | |
| SCHEMBL22671971 | 0.98 | PDK2 (0.34) | ADORA3ALOX15TSHRADORA2AADORA2B | |
| SCHEMBL23814904 | 0.98 | PDK2 (0.34) | ADORA3ALOX15TSHRADORA2AADORA2B | |
| SCHEMBL24647755 | 0.95 | MEN1 (0.33) | ADORA3ALOX15TSHRADORA2AADORA2B | |
| SCHEMBL20622674 | 0.95 | ADORA3 (0.32) | ADORA3ALOX15TSHRADORA2AADORA2B | |
| SCHEMBL20619326 | 0.95 | PDK2 (0.32) | ADORA3ALOX15TSHRADORA2AADORA2B | |
| SCHEMBL19298851 | 0.95 | ADORA3 (0.33) | ADORA3ALOX15TSHRADORA2AADORA2B | |
| SCHEMBL21651528 | 0.95 | PDK2 (0.32) | ADORA3ALOX15TSHRADORA2AADORA2B | |
| SCHEMBL15275963 | 0.95 | GP6 (0.33) | ADORA3ALOX15TSHRADORA2AADORA2B | |
| SCHEMBL21677676 | 0.94 | PDK2 (0.33) | PDK2GP6MEN1ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220376178-A1 | ORGANIC LIGHT-EMITTING DEVICE | LG CHEM, LTD. (KR) | 2022-11-24 | — | — | US | disclosed |
| US-11152576-B2 | Organic light emitting device | LG CHEM, LTD. (KR) | 2021-10-19 | — | — | US | disclosed |
| US-20210288264-A1 | Heterocyclic Compound And Organic Light Emitting Element Comprising Same | LG CHEM, LTD. (KR) | 2021-09-16 | — | — | US | disclosed |
| US-20210288260-A1 | ORGANIC LIGHT EMITTING DIODE | LG CHEM, LTD. (KR) | 2021-09-16 | — | — | US | disclosed |
| US-11094889-B2 | Heterocyclic compound and organic light emitting element comprising same | LG CHEM, LTD. | 2021-08-17 | — | — | US | disclosed |
| US-20210217967-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2021-07-15 | — | — | US | disclosed |
| US-20210143344-A1 | ORGANIC LIGHT-EMITTING DEVICE | LG CHEM, LTD. (KR) | 2021-05-13 | — | — | US | disclosed |
| US-20210020842-A1 | ORGANIC LIGHT-EMITTING DEVICE | LG CHEM, LTD. (KR) | 2021-01-21 | — | — | US | disclosed |
| US-20210013422-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2021-01-14 | — | — | US | disclosed |
| EP-3595025-B1 | ORGANIC LIGHT EMITTING ELEMENT | LG CHEMICAL LTD (KR) | 2020-12-30 | — | — | EP | disclosed |
| US-20200365814-A1 | ORGANIC LIGHT-EMITTING DEVICE | LG CHEM, LTD. (KR) | 2020-11-19 | — | — | US | disclosed |
| WO-2020022768-A1 | ORGANIC LIGHT EMITTING DIODE | 주식회사 엘지화학 | 2020-01-30 | — | — | WO | disclosed |
| WO-2020022771-A1 | ORGANIC LIGHT-EMITTING DEVICE | 주식회사 엘지화학 | 2020-01-30 | — | — | WO | disclosed |
| WO-2019004787-A1 | ORGANIC LIGHT EMITTING ELEMENT | 주식회사 엘지화학 | 2019-01-03 | — | — | WO | disclosed |
| WO-2019004782-A1 | ORGANIC LIGHT EMITTING ELEMENT | 주식회사 엘지화학 | 2019-01-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210288264-A1 | Heterocyclic Compound And Organic Light Emitting Element Comprising Same | CRY1, CRY2, PER2 | ADORA3 3245/4885ALOX15 652/4885TSHR 4112/4885 |
| US-11094889-B2 | Heterocyclic compound and organic light emitting element comprising same | CRY1, CRY2, PER2 | ADORA3 3245/4885ALOX15 652/4885TSHR 4112/4885 |
| US-20210020842-A1 | ORGANIC LIGHT-EMITTING DEVICE | OR10J3, OR51E2, LOXL1 | ADORA3 4367/4885ALOX15 373/4885TSHR 2461/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.